Skip to main content
Premium Trial:

Request an Annual Quote

SBI Hires Merck Exec to Head Drug Discovery Efforts

NEW YORK, Jan 5 – Proteomics company Structural Bioinformatics said Friday it has appointed Ian McDonald as vice president of drug discovery.

McDonald was previously senior director of chemistry at Merck Research Laboratories. He is an inventor on 32 patents in the US.

" Over the past few years, SBI has consistently demonstrated its unique ability to efficiently generate initial hits from in silico screening of virtual libraries against modeled protein structures,” McDonald said in a statement.

“I am pleased to join SBI to expand its leadership position in drug discovery as we expand our wet lab capabilities to advance these novel hits towards clinical validation,” he added.

SBI, a privately held company based in San Diego, has develops technologies to
generate 3-dimensional structural models of proteins from genetic information.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.